Sonnet Biotherapeutics Holdings Inc (SONN)

Jun 14, 2025

Two Sigma Investments LP Invests $28,000 in Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) - Defense World

Jun 14, 2025

Jun 09, 2025

Reviewing Sonnet BioTherapeutics (NASDAQ:SONN) and Madrigal Pharmaceuticals (NASDAQ:MDGL) - Defense World

Jun 09, 2025

Jun 02, 2025

sonnet biotherapeutics receives nasdaq delisting notice By Investing.com - Investing.com South Africa

Jun 02, 2025

Jun 02, 2025

sonnet biotherapeutics receives nasdaq delisting notice - Investing.com

Jun 02, 2025

Jun 02, 2025

Sonnet BioTherapeutics Faces Nasdaq Non-Compliance Notice - TipRanks

Jun 02, 2025

May 28, 2025

Sonnet BioTherapeutics (NASDAQ:SONN) Stock Price Up 5.3% – What’s Next? - Defense World

May 28, 2025

May 22, 2025

SONN stock touches 52-week low at $1.1 amid market challenges - Investing.com Australia

May 22, 2025

May 16, 2025

Sonnet Biotherapeutics Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 16, 2025

May 13, 2025

Sonnet BioTherapeutics Holdings, Inc. SEC 10-Q Report - TradingView

May 13, 2025

May 11, 2025

Sonnet BioTherapeutics (SONN) Expected to Announce Earnings on Tuesday - Defense World

May 11, 2025

May 01, 2025

Sonnet Chief Medical Officer, Richard Kenney, M.D., to - GlobeNewswire

May 01, 2025

May 01, 2025

Sonnet Chief Medical Officer, Richard Kenney, M.D., to Present at the 6th Annual Cytokine-Based Drug Development Summit - The Globe and Mail

May 01, 2025

Apr 19, 2025

Chanticleer Holdings Little Big Burger Partner and Brand Ambassador Denny Hamlin Wins the Daytona 500 - marketscreener.com

Apr 19, 2025

Apr 16, 2025

Sonnet Releases Virtual Investor "What This Means" Segment | SONN Stock News - GuruFocus

Apr 16, 2025

Apr 16, 2025

Sonnet BioTherapeutics Discusses Positive Safety Data for SON-1010 in Virtual Investor Segment - Nasdaq

Apr 16, 2025

Apr 16, 2025

Sonnet Releases Virtual Investor "What This Means" Segment - GlobeNewswire

Apr 16, 2025

Apr 15, 2025

Biotech Leader Dr. Pankaj Mohan Honored on NASDAQ After Tragic Crash - newsindiatimes.com

Apr 15, 2025

Apr 08, 2025

Sonnet BioTherapeutics (NASDAQ:SONN) Receives Buy Rating from Chardan Capital - Defense World

Apr 08, 2025

Apr 07, 2025

SONN stock touches 52-week low at $1.18 amid market challenges - Investing.com India

Apr 07, 2025

Apr 07, 2025

Sonnet BioTherapeutics reports positive results from ovarian cancer therapy trial - Yahoo Finance

Apr 07, 2025

Apr 06, 2025

Sonnet BioTherapeutics advances in cancer trial - Investing.com Australia

Apr 06, 2025

Apr 04, 2025

Sonnet BioTherapeutics Says Ovarian Cancer Drug Showed 'Positive' Safety Data in Phase 1b/2a Trial; Shares Up - MarketScreener

Apr 04, 2025

Apr 04, 2025

Sonnet BioTherapeutics advances in cancer trial By Investing.com - Investing.com South Africa

Apr 04, 2025

Apr 04, 2025

Sonnet says SON-1010 demonstrates ‘strong safety profile’ in atezolizumab combo - TipRanks

Apr 04, 2025

Apr 04, 2025

Sonnet's SON-1010 Demonstrates a Strong Safety Profile in Combination with Atezolizumab for Treatment of Platinum-Resistant Ovarian Cancer, Including a Partial Response at the Highest Dose - The Manila Times

Apr 04, 2025

Apr 04, 2025

Sonnet'S Son-1010 Demonstrates A Strong Safety Profile In Combination With Atezolizumab For Treatment Of Platinum-Resistant Ovarian Cancer - MarketScreener

Apr 04, 2025

Apr 04, 2025

Sonnet’s SON-1010 Demonstrates a Strong Safety Profile in - GlobeNewswire

Apr 04, 2025

Apr 04, 2025

Sonnet’s SON-1010 Demonstrates a Strong Safety Profile in Combination with Atezolizumab for Treatment of Platinum-Resistant Ovarian Cancer, Including a Partial Response at the Highest Dose - GlobeNewswire

Apr 04, 2025

Apr 02, 2025

Sonnet BioTherapeutics appoints interim CEO and new president By Investing.com - Investing.com Canada

Apr 02, 2025

Apr 01, 2025

Sonnet Announces Release of Corporate Update Video - GlobeNewswire

Apr 01, 2025

Apr 01, 2025

Sonnet BioTherapeutics appoints interim CEO and new president - Investing.com

Apr 01, 2025

Apr 01, 2025

Sonnet BioTherapeutics Announces New Interim CEO Appointment - TipRanks

Apr 01, 2025

Apr 01, 2025

Pilot Killed In Franklin Twp Plane Crash Was CEO Of Cancer-Focused Biotech Company - NewsBreak: Local News & Alerts

Apr 01, 2025

Apr 01, 2025

Pilot killed in N.J. plane crash was biotech company founder, CEO - NJ.com

Apr 01, 2025

Apr 01, 2025

Sonnet Announces the Passing of Founder and CEO Pankaj Mohan, Ph.D. - citybiz

Apr 01, 2025

Apr 01, 2025

Sonnet BioTherapeutics appoints interim CEO after founder’s death - Investing.com

Apr 01, 2025

Apr 01, 2025

Sonnet Announces The Passing Of Founder And CEO Pankaj Mohan - marketscreener.com

Apr 01, 2025

Mar 30, 2025

Chardan Capital Reaffirms Buy Rating for Sonnet BioTherapeutics (NASDAQ:SONN) - Defense World

Mar 30, 2025

Mar 29, 2025

Sonnet BioTherapeutics’ (SONN) Buy Rating Reaffirmed at Chardan Capital - The AM Reporter

Mar 29, 2025

Mar 28, 2025

SONN stock touches 52-week low at $1.28 amid market challenges - Investing.com Australia

Mar 28, 2025

Mar 27, 2025

Sonnet BioTherapeutics Successfully Completes First Safety - GlobeNewswire

Mar 27, 2025

Mar 26, 2025

Sonnet BioTherapeutics Successfully Completes First Safety Review Of SON-1010 In Combination With Trabectedin In Certain Sarcomas - MarketScreener

Mar 26, 2025